UB Paderborn / Katalog / Suche / in CDI

Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

PloS one, 2016-10, Vol.11 (10), p.e0164455

2016

Link zum Volltext

Verfügbarkeit prüfen

Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy

Clinical infectious diseases, 2013-11, Vol.57 (10), p.1401-1408

2013

Link zum Volltext

Verfügbarkeit prüfen

Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study

Current HIV research, 2010-10, Vol.8 (7), p.521

2010

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2019-09, Vol.39 (5), p.497-505

2019

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of HIV infection through cohort studies: a look on the past in order to influence on the future

Medicina clínica, 2010-05, Vol.134 (13), p.587-588

Suárez-Lozano, Ignacio

2010

Link zum Volltext

Verfügbarkeit prüfen

Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort

The open AIDS journal, 2008, Vol.2 (1), p.26-38

2008

Link zum Volltext

Verfügbarkeit prüfen

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort

Journal of antimicrobial chemotherapy, 2008-06, Vol.61 (6), p.1348-1358

2008

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort

Journal of antimicrobial chemotherapy, 2009-01, Vol.63 (1), p.189-196

2009

Link zum Volltext

Verfügbarkeit prüfen

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort)

AIDS (London), 2002-12, Vol.16 (18), p.2496-2499

2002

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcome of HIV infection in gypsies in the Spanish VACH Cohort

Enfermedades infecciosas y microbiologia clinica, 2010-05, Vol.28 (5), p.266-272

2010

Link zum Volltext

Verfügbarkeit prüfen

Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

PLoS medicine, 2013-09, Vol.10 (9), p.e1001510

2013

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis-B virus infection predicts mortality of HIV and hepatitis C virus coinfected patients

AIDS (London), 2013-03, Vol.27 (5), p.845-848

Teira, Ramón

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessment of clinical practice in patients with infectious meningitis

Enfermedades infecciosas y microbiología clínica, 2007-04, Vol.25 (4), p.242-246

2007

Link zum Volltext

Verfügbarkeit prüfen

Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2009-08, Vol.51 (5), p.582

2009

Link zum Volltext

Verfügbarkeit prüfen

Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain

Enfermedades infecciosas y microbiologia clinica (English ed.), 2019-06, Vol.37 (6), p.373-379

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

Nefrología, 2019-09, Vol.39 (5), p.497-505

2019

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with short-term changes in HIV viral load and CD4+ cell count in antiretroviral-naive individuals

AIDS (London), 2014-06, Vol.28 (9), p.1351-1356

Anon

2014

Link zum Volltext

Verfügbarkeit prüfen

Response to Combined Antiretroviral Therapy According to Gender and Origin in a Cohort of Naïve HIV-Infected Patients: GESIDA-5808 Study

HIV clinical trials, 2012-05, Vol.13 (3), p.131-141

2012

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

Nefrología, 2019-09, Vol.39 (5), p.497-505

2019

Link zum Volltext

Verfügbarkeit prüfen

Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors

Enfermedades infecciosas y microbiologia clinica (English ed.), 2019-06, Vol.37 (6), p.361-366

2019

Link zum Volltext

Verfügbarkeit prüfen

Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain

Enfermedades infecciosas y microbiologia clinica (English ed.), 2019-06, Vol.37 (6), p.373-379

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy

Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study

Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

Epidemiology of HIV infection through cohort studies: a look on the past in order to influence on the future

Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort

Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals : results from an inter-cohort analysis

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort

Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort)

Characteristics and outcome of HIV infection in gypsies in the Spanish VACH Cohort

Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

Hepatitis-B virus infection predicts mortality of HIV and hepatitis C virus coinfected patients

Assessment of clinical practice in patients with infectious meningitis

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy

Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain

Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

Factors associated with short-term changes in HIV viral load and CD4+ cell count in antiretroviral-naive individuals

Response to Combined Antiretroviral Therapy According to Gender and Origin in a Cohort of Naïve HIV-Infected Patients: GESIDA-5808 Study

Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors

Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain

Suchergebnisse filtern